Skip to content

Clinical trials

Completed Phase 2 Immune System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 2 Status: Completed Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20092
20102
20141
20151
20163
20171
20184
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)5
AstraZeneca2
Pfizer2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Altair Therapeutics, Inc.1
BioTech Tools S.A.1
Calibra Medical, Inc.1
Charles Drew University of Medicine and Science1
Dermata Therapeutics1
Diamyd Medical AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases29
Communicable Diseases9
Rare Diseases9
Autoimmune Diseases6
Hypersensitivity5
Lupus Erythematosus, Systemic4
Skin Diseases4
Bacterial Infections3
Dermatitis3
Dermatitis, Atopic3

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.